A Baby's Custom CRISPR Cure Marks a Medical Milestone
Baby KJ, born with the rare and often-fatal metabolic disorder CPS1 deficiency, became the world's first patient treated with a personalized CRISPR gene-editing therapy — developed by CHOP and Penn Medicine in just six months.
Open story